Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Cabozantinib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cabozantinib 20mg capsules
0801050BRAAAAAA
|
Cabozantinib | Cabozantinib | Malignant Disease and Immunosuppression | No data available |
|
Cabozantinib 20mg capsules and Cabozantinib 80mg capsules
0801050BRAAABAB
|
Cabozantinib | Cabozantinib | Malignant Disease and Immunosuppression | No data available |
|
Cabozantinib 20mg tablets
0801050BRAAACAC
|
Cabozantinib | Cabozantinib | Malignant Disease and Immunosuppression | No data available |
|
Cabozantinib 40mg tablets
0801050BRAAADAD
|
Cabozantinib | Cabozantinib | Malignant Disease and Immunosuppression | No data available |
|
Cabozantinib 60mg tablets
0801050BRAAAEAE
|
Cabozantinib | Cabozantinib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.